Drug Discovery & Pharmaceuticals

RSS

Beckman Coulter Life Sciences and HSE•AG partner to revolutionize nucleic acid quantification and purification through liquid handling

Beckman Coulter Life Sciences, a Danaher company and global leader in laboratory automation and innovation, is redefining nucleic acid quantification through a strategic collaboration with Hombrechtikon Systems Engineering•AG (HSE•AG), a Swiss provider of customized automation and engineering solutions for the life sciences and diagnostics sectors.

From Beckman Coulter Life Sciences 4 Sep 2025

TRIMTECH Therapeutics establishes Scientific Advisory Board

TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the formation of its Scientific Advisory Board (SAB).

From TRIMTECH Therapeutics 3 Sep 2025

Generative AI creates life-saving antibiotics from scratch

What if generative AI could design life-saving antibiotics, not just art and text? In a new Cell Biomaterials paper, Penn researchers introduce AMP-Diffusion, a generative AI tool used to create tens of thousands of new antimicrobial peptides (AMPs) - short strings of amino acids, the building blocks of proteins - with bacteria-killing potential.

2 Sep 2025

Aptamer signs therapeutic development agreement with Invizius

Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce that it has signed a new therapeutic development agreement with Invizius, a clinical-stage biotechnology company focused on second-generation complement system therapies for inflammatory, fibrotic, and autoimmune diseases.

From Aptamer Group 2 Sep 2025

New reaction approach expands possibilities for drug discovery building blocks

A new approach to an established reaction boosts the ability to synthesize vinylic ethers - key building blocks for many molecules important to human health.

28 Aug 2025

Aptamer Group introduces novel biomarker discovery service

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to identify and validate new disease markers.

28 Aug 2025

Qureight's AI 3D imaging platform to support Calluna Pharma's Phase 2 AURORA study of CAL101 in idiopathic pulmonary fibrosis (IPF)

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, today announced that it has been selected by Calluna Pharma to support its Phase 2 AURORA study.

27 Aug 2025

Indole chemistry breakthrough opens doors for more effective drug synthesis

Indole, a molecule made up of a six-membered benzene ring fused to a five-membered ring containing nitrogen, forms the core structure of many biologically active compounds.

25 Aug 2025

Balancing speed and selectivity is key for designing effective targeted covalent inhibitors

One class of drugs that has shown promise in treating diseases ranging from lung cancer to COVID-19 are targeted covalent inhibitors (TCIs).

22 Aug 2025

University of Vienna team develops method to measure molecular charges

An international research team led by the University of Vienna has succeeded in developing a new method to directly measure partial charges in molecules. The results, now published in Nature, provide new insights into molecular interactions and offer potential applications in drug development and materials science.

22 Aug 2025

Nanodroplet array revolutionizes search for new drugs

Until now, the early phase of drug discovery for the development of new therapeutics has been both cost- and time-intensive.

21 Aug 2025

AI predicts designer drug structures for improved detection

How does one identify something no one has a test for? Designer drugs replicate the effects of known, illicit drugs but evade law enforcement. The chemical structure variations that help these compounds avoid detection also make them unpredictable in the body - a quality that poses serious health consequences.

21 Aug 2025

Artificial intelligence enables discovery of novel compounds to fight drug-resistant bacteria

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA).

14 Aug 2025

Camena Bioscience and Constructive Bio join synthetic biology collaboration to develop plant genomics

Camena Bioscience (Camena), an innovator in enzymatic DNA synthesis, and Constructive Bio (Constructive), a pioneer in whole genome writing, today announced they have joined a collaborative project led by the Max-Planck Institute of Molecular Plant Physiology (MPI-MP), Germany, for a research initiative to develop synthetic chloroplast genomes.

14 Aug 2025

New drug discovery platform aims to deliver first-in-class therapies

65LAB has awarded US$1.5 million (approx. S$1.9 million) to Professor Enrico Petretto to advance a breakthrough drug discovery platform developed at Duke-NUS Medical School. The project aims to deliver first-in-class antifibrotic therapies for lung and kidney diseases-conditions that currently have no effective treatment.

14 Aug 2025

AI breakthrough designs peptide drugs to target previously untreatable proteins

A study published in Nature Biotechnology reveals a powerful new use for artificial intelligence: designing small, drug-like molecules that can stick to and break down harmful proteins in the body - even when scientists don't know what those proteins look like.

13 Aug 2025

Nudibranchs (sea slugs) emerge as a promising source of cancer drugs

Researchers reviewed the antitumor potential of bioactive compounds from nudibranchs, marine mollusks that acquire or synthesize potent chemical defenses. These compounds, often sourced from their diet, show promising cancer-fighting activity through mechanisms like DNA damage, oxidative stress, and apoptosis.

12 Aug 2025

AI discovers promising antibiotic compounds in Archaea microbes

They've survived for billions of years in boiling acid, deep-sea vents and salt flats. Now, some of Earth's oldest life forms - microbes called Archaea - are offering a new weapon in the fight against one of today's most urgent health threats: antibiotic resistance.

12 Aug 2025

Sunil Shah and Dr Catherine Elton join Atelerix's Board to drive global commercial expansion

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced the appointments of Sunil Shah as Chair of the Board and Dr Catherine Elton as Non-Executive Director.

12 Aug 2025

Newly discovered drug class could someday lead to breakthrough treatments for fungal infections

A research team at McMaster University has discovered a new drug class that could someday lead to breakthrough treatments for dangerous fungal infections.

11 Aug 2025

Drug Discovery & Pharmaceuticals

Beckman Coulter Life Sciences and HSE•AG partner to revolutionize nucleic acid quantification and purification through liquid handling

TRIMTECH Therapeutics establishes Scientific Advisory Board

Generative AI creates life-saving antibiotics from scratch

Aptamer signs therapeutic development agreement with Invizius

New reaction approach expands possibilities for drug discovery building blocks

Aptamer Group introduces novel biomarker discovery service

Qureight's AI 3D imaging platform to support Calluna Pharma's Phase 2 AURORA study of CAL101 in idiopathic pulmonary fibrosis (IPF)

Indole chemistry breakthrough opens doors for more effective drug synthesis

Balancing speed and selectivity is key for designing effective targeted covalent inhibitors

University of Vienna team develops method to measure molecular charges

Nanodroplet array revolutionizes search for new drugs

AI predicts designer drug structures for improved detection

Artificial intelligence enables discovery of novel compounds to fight drug-resistant bacteria

Camena Bioscience and Constructive Bio join synthetic biology collaboration to develop plant genomics

New drug discovery platform aims to deliver first-in-class therapies

AI breakthrough designs peptide drugs to target previously untreatable proteins

Nudibranchs (sea slugs) emerge as a promising source of cancer drugs

AI discovers promising antibiotic compounds in Archaea microbes

Sunil Shah and Dr Catherine Elton join Atelerix's Board to drive global commercial expansion

Newly discovered drug class could someday lead to breakthrough treatments for fungal infections

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Latest Life Science News